509MO Datopotamab deruxtecan (Dato-DXd) vs docetaxel in previously treated advanced/metastatic (adv/met) non-small cell lung cancer (NSCLC): Results of the randomized phase III study TROPION-Lung01
| Autor: | Ahn, M-J., Lisberg, A.E., Paz-Ares, L., Cornelissen, R., Girard, N., Pons-Tostivint, E., Vicente Baz, D., Sugawara, S., Cobo Dols, M., Pérol, M., Mascaux, C., Poddubskaya, E., Kitazono, S., Hayashi, H., Sands, J., Hall, R., Zhang, Y., Zebger-Gong, H., Uema, D., Okamoto, I. |
|---|---|
| Zdroj: | In Annals of Oncology November 2023 34 Supplement 4:S1665-S1666 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|